Royalty Pharma (RPRX)
Royalty Pharma Declares Second Quarter 2026 Dividend
Royalty Pharma Declares Second Quarter 2026 Dividend
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
Gilead - Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
Schrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Badger Meter Reports First Quarter 2026 Financial Results
Alliance Entertainment’s Handmade by Robots debuts Record Store Day Exclusive Figures
Cinemark to Host First Quarter 2026 Earnings Conference Call